www.rttnews.com/1979854/nymox-nx-1207-prostate-cancer-trial-gets-positive-interim-safety-review-fromidmc.aspx?type=qf&utm_source=google&utm_campaign=sitemapNX-1207 is in Phase II trial for early localized prostate cancer. It is in Phase III trial for BPH. It is an injection directly into the prostate tissue.
Post Edited (robertcool) : 10/9/2012 1:53:15 PM (GMT-6)